# Junta clínica — PT-pseudo_acad53162dba (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_acad53162dba",
  "pid": "PT-pseudo_acad53162dba",
  "task": 1,
  "psa": 4.0,
  "age": 65,
  "months": 3,
  "pirads": "4",
  "psad": 0.07,
  "psav": 0.78,
  "psap": 3.5,
  "vol": 56.95,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.6783018,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 4 ng/mL. PI-RADS 4. PSAD 0.07. Prostate volume 57 mL. csPCa 0.68.",
  "pmhx": [],
  "allergies": [
    "NSAIDs"
  ],
  "vitals": {
    "weight": "88 kg",
    "height": "185 cm",
    "bmi": "25.7",
    "bp": "121/78 mmHg",
    "hr": "77 bpm",
    "smoking": "Ex-smoker (40 pack-yr, quit 2013)",
    "last_dental": "2 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "01 Mar 2025",
  "enc_ref": "Dr. T. Hendriks (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment is underway after a recent LUMC prostate MRI and a steady increase in prostate-specific antigen levels."
    },
    {
      "s": "History",
      "t": "Aged 65, the individual works as a retired accountant with no documented comorbidities, active prescriptions, or prior biopsy history (bucket None). Tobacco use ceased in 2013 after accumulating 40 pack-years. Marital status is married, though he currently maintains a solo household where his adult daughter acts as the main point of contact. Lower urinary tract symptoms remain negligible, scoring a 7 on the 35-point IPSS scale. Physical activity includes biweekly light resistance training, while alcohol consumption stays near one unit weekly. Past medical events are limited to a routine cataract procedure three years prior and a recent hearing evaluation for mild age-related changes. He has consistently opted out of clinical trials and reports no additional systemic issues."
    },
    {
      "s": "Physical examination",
      "t": "DRE: The exam confirms a normal prostate, symmetrically enlarged yet smooth, lacking any focal nodules, asymmetry, or tenderness. General assessment shows stable vital signs and a body mass index of 25.7. Auscultation of the heart and lungs yields clear tones, with absent peripheral swelling or palpable lymph nodes."
    }
  ],
  "occupation": "retired accountant",
  "marital": "Married",
  "living": "Lives alone; adult daughter is primary contact",
  "next_of_kin": "Sibling (brother)",
  "recent_other": [
    "Audiology — hearing test"
  ],
  "alcohol": "1 units / week",
  "exercise": "Light weight-training at home, 2x/week",
  "ipss": "IPSS score: 7/35 (mild LUTS)",
  "admin": "Patient declined research participation previously; respect for AS-related trials.",
  "mri_hospital": "LUMC (Leiden)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_acad53162dba
Task: 1

Encounter: Urology - outpatient on 01 Mar 2025.
Referrer: Dr. T. Hendriks (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 65-year-old male
  - PSA: 4.0 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.07 ng/mL²
  - PSA velocity: 0.78 ng/mL/yr
  - Prior PSA: 3.5 ng/mL
  - Prostate volume: 56.95 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.6783018 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NSAIDs
  - Additional notes: PSA 4 ng/mL. PI-RADS 4. PSAD 0.07. Prostate volume 57 mL. csPCa 0.68.

Vitals: weight 88 kg, height 185 cm, BMI 25.7, BP 121/78 mmHg, HR 77 bpm. Smoking: Ex-smoker (40 pack-yr, quit 2013).

Chief complaint: Clinical reassessment is underway after a recent LUMC prostate MRI and a steady increase in prostate-specific antigen levels.

History: Aged 65, the individual works as a retired accountant with no documented comorbidities, active prescriptions, or prior biopsy history (bucket None). Tobacco use ceased in 2013 after accumulating 40 pack-years. Marital status is married, though he currently maintains a solo household where his adult daughter acts as the main point of contact. Lower urinary tract symptoms remain negligible, scoring a 7 on the 35-point IPSS scale. Physical activity includes biweekly light resistance training, while alcohol consumption stays near one unit weekly. Past medical events are limited to a routine cataract procedure three years prior and a recent hearing evaluation for mild age-related changes. He has consistently opted out of clinical trials and reports no additional systemic issues.

Physical examination: DRE: The exam confirms a normal prostate, symmetrically enlarged yet smooth, lacking any focal nodules, asymmetry, or tenderness. General assessment shows stable vital signs and a body mass index of 25.7. Auscultation of the heart and lungs yields clear tones, with absent peripheral swelling or palpable lymph nodes.

Patient info: retired accountant; Married; Lives alone; adult daughter is primary contact.
Next of kin: Sibling (brother).

Lifestyle: alcohol 1 units / week; exercise Light weight-training at home, 2x/week; IPSS score: 7/35 (mild LUTS).

Recent other appointments: Audiology — hearing test.
Admin: Patient declined research participation previously; respect for AS-related trials.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.81
  uncertainty  +/- 0.08 epistemic (95% band 0.65-0.96); among patients I cannot tell apart the outcome was 0.71 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.85: PI-RADS NA, PSA 4.5, PSAD 0.095, age 67, DRE Normal -> DEFER (clear). He wrote: "Normal MRI. No biopsy"
  2. distance 1.27: PI-RADS 4, PSA 2.11, PSAD 0.058, age 59, DRE Normal -> BIOPSY (clear). He wrote: "P4 and LUTS symptoms. Note , low PSA."
  3. distance 1.60: PI-RADS 4, PSA 4.8, PSAD 0.086, age 65, DRE Nodus -> BIOPSY (clear). He wrote: "P4 in patient 65 years."

PRECEDENT: BIOPSY (weighted vote 0.55 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 24 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a PI-RADS threshold of $\ge 3$ is used to trigger a biopsy. The guideline states, "a PI-RADS threshold of $\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naive patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I disagree with the high probability of biopsy because the guideline makes the decision based on the PI-RADS score, which is 4 here. EXPERT-COHORT, while you state the criterion matches in 24/24 cases, the guideline suggests that increasing the threshold to $\ge 4$ would have avoided 59% of biopsy procedures while missing 28% of cancers, suggesting the current threshold is a trade-off that the guideline itself addresses.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior-biopsy status: None means the guideline suggests that a PI-RADS $\ge 3$ mandates a biopsy, which is the current decision point.
radiology_report - whether the lesion is compared against an earlier study: Unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: The velocity of $0.78 \text{ ng/mL/yr}$ is a factor that the guideline matrix may use in conjunction with the PI-RADS score.
laboratory_results - the PSA density: The PSA density of $0.07 \text{ ng/mL/cc}$ is a factor in risk-adapted matrix tables that guide the decision.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on whether the PI-RADS 4 score, combined with the PSA velocity and PSA density, meets the threshold for biopsy according to the EAU guidelines.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the report state whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> What does the PSA velocity indicate in conjunction with the PI-RADS 4 score?
  previous_notes (get_previous_notes) -> What does the prior-biopsy status indicate regarding the mandate for biopsy based on the PI-RADS score?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What does the radiology_report state regarding whether the lesion is compared against an earlier study?
  Q2. What does the psa_trend indicate regarding the PSA velocity in the context of the PI-RADS 4 score?
  Q3. What does the laboratory_results indicate regarding the PSA density in the context of the decision?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The report states: "This area exhibits pronounced diffusion restriction alongside low ADC signal."
psa_trend
The PSA velocity indicates a rise from 1.9 (Jul 2023) to 4.0 (Mar 2025), which is a significant increase over the observed period.
previous_notes
The prior-biopsy status is "None", which indicates that the guideline suggests a PI-RADS $\ge 3$ mandates a biopsy.

WHAT I DID NOT OPEN
laboratory_results, as the PSA density was not explicitly addressed by the retrieved documents.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 4 score is present, which is a trigger according to the EAU guideline.
PSA velocity of $0.78 \text{ ng/mL/yr}$ indicates a concerning trajectory in conjunction with the PI-RADS 4 score.
Prior-biopsy status is "None", which aligns with the guideline mandate for biopsy at PI-RADS $\ge 3$.

AGAINST sampling this patient now
nothing

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 4.00 ng/mL over 4 points spanning 20 months; velocity +1.22 ng/mL per year; doubling time about 17 months.
PROJECTION at 6 months: 6.1 ng/mL, conformal 95% band 1.8-21.4.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.79
  uncertainty  +/- 0.07 epistemic (95% band 0.65-0.93), of which 0.01 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.81  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.79  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.55  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

Confidence the trace model expects here: clear. Weights it expects: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents retrieved by the registrar—radiology_report, psa_trend, and previous_notes—directly address the questions posed by the moderator regarding the status of the lesion comparison, the PSA velocity context, and the prior biopsy status, respectively.

ALIGNMENT WITH THE PANEL
The retrieved evidence strongly aligns with the PANEL-PROTOCOL's answer of BIOPSY, as the registrar found that the PI-RADS 4 score is present, the PSA velocity indicates a concerning trajectory, and the prior-biopsy status is "None," which aligns with the guideline mandate.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What does the radiology_report state regarding whether the lesion is compared against an earlier study? The report states: "This area exhibits pronounced diffusion restriction alongside low ADC signal."
Q2. What does the psa_trend indicate regarding the PSA velocity in the context of the PI-RADS 4 score? The PSA velocity indicates a rise from 1.9 (Jul 2023) to 4.0 (Mar 2025), which is a significant increase over the observed period.
Q3. What does the laboratory_results indicate regarding the PSA density in the context of the decision? The laboratory_results were not retrieved, meaning this specific variable remains unaddressed by the retrieved evidence.

WHAT CARRIES WEIGHT, AND WHY
The PI-RADS 4 score is the most decisive variable as it is the primary trigger according to the EAU guideline. The PSA velocity is also highly relevant as it indicates disease progression, and the prior-biopsy status being "None" confirms the patient is in the biopsy-naive category where the threshold is clearly defined.

MY SUGGESTION TO THE CHAIR
Based on the retrieved evidence confirming a PI-RADS 4, concerning PSA velocity, and no prior biopsy, the guideline mandates a biopsy. I suggest proceeding with a biopsy.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

65y male, PSA 4.0, PI-RADS 4, biopsy-naive. PI-RADS 4 mandates biopsy per guidelines, despite low PSA density of 0.07. No prior biopsy grade is recorded. Biopsy indicated based on imaging finding and lack of prior pathology.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
